Global Pharmacy Compounding for Veterinary Medicine Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,475	99 Pages	Evolve Business Intelligence	January, 2022	EVBI17553354

Best Price Guarantee
Price	from $3,475
Length	99 Pages
Publisher	Evolve Business Intelligence
Published Date	January, 2022
SKU	EVBI17553354

Global Pharmacy Compounding for Veterinary Medicine Market

The global Pharmacy Compounding for Veterinary Medicine market size was valued at $954.61 Million in 2021 growing at the CAGR of 6.14% from 2022 to 2030. This growth is attributed to several macro and microeconomic factors such as

Increasing expenditure on Pets

Owners consider their pets as family members and are highly concerned about their wellbeing. Pet owners have increased their spending on the health and wellness of their pets. The increasing income has influenced the pet adoption rate. The pet owners are also opting for pet insurance for the medical expenses of their companion animals with the increasing disposable income. According to the American Pet Products Association survey 2019 and 2020, a total of $95.70 billion was spent on pets in the year 2019 and it is expected to reach $99.0 billion in the year 2020. In 2019, $19.2 billion was spent on supplies and OTC medicines. The annual expenditure of an owner of dogs for a surgical vet visit and routine vet visits is $426 and $212 respectively and the annual expenditure on cats for the surgical vet and routine vet visits is $214 and $160 respectively. Pet insurance covers expenses including chronic conditions, diagnostic testing, accidents, medication coverage, and routine care coverage. According to the North American Pet Insurance Association, the pet health insurance with total premium volume in North America has reached $1.42 billion in 2018. In the US, the average accident and illness premium for dogs and cats was $566 or $47/month and $354 or $29.50/month respectively. A total of 2.43 million pets were insured in North America in the year 2018. The continuous increase in expenditure on pets has increased the demand for better treatment of animals which is anticipated to supplement pharmacy compounding for veterinary medicine market growth during the next few years.

Further several factors restraining the market growth include

Monitoring Health through Pet Wearables

The sifting focus of pet and livestock owners towards adopting preventive measured through wearable is expected to reduce the dependency on medicines. The concern of the owners towards their pet health has exponentially increased the demand for pet wearable devices. The pet wearable device developing companies are focusing on the integration of new features in their devices such as various sensors to measure temperature, heart rate, calorie intake, respiration, blood pressure, and so on are implemented in the pet wearable devices together with GPS and other wireless communication techniques. These developments have led to not only tracking the location of the pet but also helping in real-time monitoring of fitness, sleep, behavior, and food intake. To monitor and control the health of their companion pets, owners are spending a reasonable amount on pet health and fitness products, especially wearable devices. With the increasing awareness for pet safety and health globally, the pet wearable device market is growing largely. These pet wearables may reduce the need for compounding pharmacies. Furthermore, with the availability of low-cost sensors, the cost of pet wearable devices is decreasing. Also, the implementation of IoT, smartphone applications, and in-built GPS tracking systems are expected to develop hurdles for pharmacy compounding for veterinary medicine market growth.

Collaborations and Alliances in the Pharmacy Compounding for Veterinary Medicine market is expected to generate higher avenues during the forecast period.

In the wake of the COVID-19 pandemic, supply chain disruptions have led to supply shortages or lower demand in the Pharmacy Compounding for Veterinary Medicine market. The pandemic has caused a decline in new orders and a corresponding decrease in production.

This section will analyze how COVID-19 has impacted supply chains, leading to shortages and lower demand for Pharmacy Compounding for Veterinary Medicines.

In terms of COVID 19 impact, the Pharmacy Compounding for Veterinary Medicine market report also includes the following data points:

Impact on Pharmacy Compounding for Veterinary Medicine market size
Operating Weights Trend, Preferences, and Budget Impact
Regulatory Framework/Government Policies
Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
Opportunity in Pharmacy Compounding for Veterinary Medicine market

Key Insight in the report:
The global Pharmacy Compounding for Veterinary Medicine market report covers executive summary, market dynamics, COVID impact & post COVID scenario, market size and forecast, competitive intelligence, market positioning, and product offerings.

Our report covers extensive competitive intelligence which includes the following data points:

Business Overview
Business Segment Data
Financial Data
Product Segment Analysis and Specification
Recent Development and Company Strategy Analysis
SWOT Analysis

Pharmacy Compounding for Veterinary Medicine Market Segmentation:

Type
CNS Agents
Anti-Infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
Application
Companion Animal
Livestock Animal

Region/ Countries Covered:

North America
US
Canada
Mexico
Europe
UK
Germany
France
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Rest of Asia Pacific
Rest of the World
South America
Middle East & Africa

Key Players Analyzed in the Report:

Triangle Compounding Pharmacy Inc.
Essential Wellness Pharmacy
Lorraine's Pharmacy
MEDISCA
Central Drugs Compounding Pharmacy
Golden Gate Veterinary Compounding Pharmacy
Wedgewood Pharmacy
Slade Pharmacy
Pace Pharmacy
Vertisis custom Pharmacy

REPORT CONTENT:

High-level analysis of the current and future market trends and opportunities
Detailed analysis on current market drivers, restraining factors, and opportunities in the future
Pharmacy Compounding for Veterinary Medicine market estimates for 2022 and forecast from 2022 to 2030
Vendor market share analysis at each product level
Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.

Target Audience

Manufacturers
Suppliers and traders
Government, associations, and industrial bodies
Investors and trade experts
Consulting Firms or Individual Consultant
Anyone interested in understanding the industry dynamics of the Pharmacy Compounding for Veterinary Medicine market

CHAPTER 1. ExecutiveSummary
CHAPTER 2. Scope of the Study: 2.1. Market Definition; 2.2. Market Scope & Segmentation; 2.2.1. Objective of Report
CHAPTER 3. Evolve BI Methodology: 3.1. Data Collection & Validation Approach; 3.2. Market Size Estimation and Forecast
CHAPTER 4. Market Insights and Trends: 4.1. Value/Supply Chain Analysis; 4.1.1. Raw material providers; 4.1.2. Manufacturing Process; 4.1.3. Distribution Channel; 4.1.4. End-User; 4.2. Porter’s Five Forces Analysis; 4.2.1. Bargaining Power of Buyers; 4.2.2. Bargaining Power of Suppliers; 4.2.3. Threat of New Entrant; 4.2.4. Threat of Substitute; 4.2.5. Industry Rivalry; 4.3. COVID-19 Impact and Post COVID Scenario on Pharmacy Compounding for Veterinary Medicine Market; 4.3.1. Impact of COVID-19; 4.3.2. Government Aids and Policies for Industry Revival; 4.3.3. Companies Recent Developments to tackle Negative Impact; 4.3.4. Opportunity Window & Post COVID Trend
CHAPTER 5. Market Dynamics: 5.1. Introduction; 5.2. Drivers; 5.2.1. Increasing expenditure on Pets; 5.2.2. Expeditiously developing regulations encourages constant innovations in the animal drug compounding market; 5.2.3. Advancements in veterinary medical therapies for meeting the emerging needs for patient-specific prescriptions; 5.3. Restraints; 5.3.1. Monitoring Health through Pet Wearables; 5.3.2. Increasing Invasion of Counterfeit Drugs; 5.4. Opportunity; 5.4.1. Collaborations and Alliances
CHAPTER 6. Global Pharmacy Compounding for Veterinary Medicine, By Application: 6.1. Introduction; 6.1.1. Companion Animal; 6.1.2. Livestock Animal
CHAPTER 7. Global Pharmacy Compounding for Veterinary Medicine, By Type: 7.1. Introduction; 7.1.1. CNS Agents; 7.1.2. Anti-Infective Agents; 7.1.3. Hormones and Substitutes; 7.1.4. Anti-inflammatory Agents
CHAPTER 8. Global Pharmacy Compounding for Veterinary Medicine Market, By Country: 8.1. Introduction; 8.2. North America; 8.2.1. North America: Market Size and Forecast, By Country; 8.2.2. North America: Market Size and Forecast, By Application; 8.2.3. North America: Market Size and Forecast, By Type; 8.2.4. US; 8.2.4.1. US: Bulk Substance vs FDA approved Drugs Share, 2021; 8.2.4.2. US: Market Size and Forecast, By Application; 8.2.4.3. US: Market Size and Forecast, By Type; 8.2.5. Canada; 8.2.5.1. Canada: Market Size and Forecast, By Application; 8.2.5.2. Canada: Market Size and Forecast, By Type; 8.2.6. Mexico; 8.2.6.1. Mexico: Market Size and Forecast, By Application; 8.2.6.2. Mexico: Market Size and Forecast, By Type; 8.3. Europe; 8.3.1. Europe: Market Size and Forecast, By Country; 8.3.2. Europe: Market Size and Forecast, By Application; 8.3.3. Europe: Market Size and Forecast, By Type; 8.3.4. UK; 8.3.4.1. UK: Market Size and Forecast, By Application; 8.3.4.2. UK: Market Size and Forecast, By Type; 8.3.5. Germany; 8.3.5.1. Germany: Market Size and Forecast, By Application; 8.3.5.2. Germany: Market Size and Forecast, By Type; 8.3.6. France; 8.3.6.1. France: Market Size and Forecast, By Application; 8.3.6.2. France: Market Size and Forecast, By Type; 8.3.7. Italy; 8.3.7.1. Italy: Market Size and Forecast, By Application; 8.3.7.2. Italy: Market Size and Forecast, By Type; 8.3.8. Rest of Europe; 8.3.8.1. Rest of Europe: Market Size and Forecast, By Application; 8.3.8.2. Rest of Europe: Market Size and Forecast, By Type; 8.4. Asia Pacific; 8.4.1. Asia Pacific: Market Size and Forecast, By Country; 8.4.2. Asia Pacific: Market Size and Forecast, By Application; 8.4.3. Asia Pacific: Market Size and Forecast, By Type; 8.4.4. China; 8.4.4.1. China: Market Size and Forecast, By Application; 8.4.4.2. China: Market Size and Forecast, By Type; 8.4.5. Japan; 8.4.5.1. Japan: Market Size and Forecast, By Application; 8.4.5.2. Japan: Market Size and Forecast, By Type; 8.4.6. India; 8.4.6.1. India: Market Size and Forecast, By Application; 8.4.6.2. India: Market Size and Forecast, By Type; 8.4.7. South Korea; 8.4.7.1. South Korea: Market Size and Forecast, By Application; 8.4.7.2. South Korea: Market Size and Forecast, By Type; 8.4.8. Rest of Asia Pacific; 8.4.8.1. Rest of Asia Pacific: Market Size and Forecast, By Application; 8.4.8.2. Rest of Asia Pacific: Market Size and Forecast, By Type; 8.5. Rest of the World; 8.5.1. Rest of the World: Market Size and Forecast, By Region; 8.5.2. Rest of the World: Market Size and Forecast, By Application; 8.5.3. Rest of the World: Market Size and Forecast, By Type; 8.5.4. Middle East & Africa; 8.5.4.1. Middle East & Africa: Market Size and Forecast, By Application; 8.5.4.2. Middle East & Africa: Market Size and Forecast, By Type; 8.5.5. South America; 8.5.5.1. South America: Market Size and Forecast, By Application; 8.5.5.2. South America: Market Size and Forecast, By Type
CHAPTER 9. Competitive Landscape: 9.1. Global Pharmacy Compounding for Veterinary Medicine Key Players Positioning; 9.2. Global Pharmacy Compounding for Veterinary Medicine Market Key Players Revenue
CHAPTER 10. Company Profiles: 10.1. TRIANGLE COMPOUNDING PHARMACY INC.; 10.1.1. Business Overview; 10.1.2. Product Portfolio; 10.1.3. Recent Development and Strategies Adopted; 10.2. Essential Wellness Pharmacy; 10.2.1. Business Overview; 10.2.2. Product Portfolio; 10.2.3. Recent Development and Strategies Adopted; 10.3. Lorraine's Pharmacy; 10.3.1. Business Overview; 10.3.2. Product Portfolio; 10.3.3. Recent Development and Strategies Adopted; 10.4. MEDISCA; 10.4.1. Business Overview; 10.4.2. Product Portfolio; 10.4.3. Recent Development and Strategies Adopted; 10.4.4. SWOT Analysis; 10.5. Central Drugs Compounding Pharmacy; 10.5.1. Business Overview; 10.5.2. Product Portfolio; 10.5.3. Recent Development and Strategies Adopted; 10.5.4. SWOT Analysis; 10.6. Golden Gate Veterinary Compounding Pharmacy; 10.6.1. Business Overview; 10.6.2. Product Portfolio; 10.6.3. Recent Development and Strategies Adopted; 10.6.4. SWOT Analysis; 10.7. WEDGEWOOD PHARMACY; 10.7.1. Business Overview; 10.7.2. Product Portfolio; 10.7.3. Recent Development and Strategies Adopted; 10.7.4. SWOT Analysis; 10.8. Slade Dispensary Services; 10.8.1. Business Overview; 10.8.2. Product Portfolio; 10.8.3. Recent Development and Strategies Adopted; 10.9. Pace pharmacy; 10.9.1. Business Overview; 10.9.2. Product Portfolio; 10.9.3. Recent Development and Strategies Adopted; 10.10. VERTISIS CUSTOM PHARMACY; 10.10.1. Business Overview; 10.10.2. Product Portfolio; 10.10.3. Recent Development and Strategies Adopted